A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Head and Neck Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Lei Liu, M.D.) · liuleihx@gmail.com · +86-028-85422114

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chongqing, China · Chengdu, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

PDT For Induction Therapy For Head And Neck Cancer

Squamous Cell Carcinoma · Head and Neck Cancer Squamous Cell Carcinoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Boston, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States